Don't worry bout the mule, just load the wagon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PFE getting a bit puffy. They project about twice as much as there BioNtech says. They better do some firing, hiring and lots of buying especially as more lawsuits mount up almost weekly.
https://www.biospace.com/article/biontech-misses-q1-analyst-expectations-for-earnings-revenue-on-lowercovid-19-sales/?_gl=1*1643c2g*_up*MQ..*_ga*OTYwNDc4NzUuMTcxNDc0OTc0OQ..*_ga_DXDENFX4SY*MTcxNTAwMjIxMS4yLjAuMTcxNTAwMjIxMS4wLjAuMA..*_ga_Q90M6MWJZ4*MTcxNTAwMjIxMS4yLjAuMTcxNTAwMjIxMS4wLjAuMA..&_hsenc=p2ANqtz-8Mna_rQVBtzAnbRcd01wu-NXP5Uj9135JfbkmYcCiBqLKJD-zOgQMT_1_cUghgEy36orS64gM-29wSMt9sGmKLf5xhvw&_hsmi=305808870
LMAO, ARE YOU MAD YET?
Someone got 30 million but not me. Sad 😪
Guess it is time for twos. Oh well oh well.
$NBRI$
Still can't get my ones filled. What gives? Someone is loading on the inside along with market makers. They know what is coming.
Yep, may have to settle for more twos. Maybe I can get some naysayers to short down here. LMAO.
TIK TOK
$NBRI$
From a scammers prospective I suppose you are well represented among those who deny just about any company no matter the industry.
I sure liked Perry. He made me money. Now, I focus on the future which is beginning to shine and glisten like GOLD!!
Good luck shortie. Ya gonna need it. The rush is on in case you haven't noticed.
$NBRI$
Had the FDA/CDC done their job correctly our competition for the jab would have never seen these great losses as people
wake up to the fraud. Pigeon posters can't turn that around as much as their bosses would like it to which in my opinion is
comprised of some our own 13D. Now is this sabotage legal? Go Sidley, there is much to discover if you haven't already.
The truth always has a way of being revealed. TIK TOK pigeons. $CYDY$ 2024 Leronlimab, the one that should have been granted EUA but for some pig pharma biased scoundrels at the FDA as we saw by their emails.... what else will legal eagle Sidley uncover as we pick apart AmarX??
BioNTech’s total revenue in the first quarter of 2024 nosedived to around $202 million, a sharp decline from nearly $1.38 billion during the same time period last year, the German biotech reported on Monday.
BioNTech suffered a net loss of almost $340 million during Q1, or $1.41 per share. Analysts had expected a $0.78 drop in earnings per share (EPS), according to stocks analysis firm Zacks Investment Research. By comparison, in Q1 of 2023, BioNTech reported a net profit of approximately $541 million, or $2.21 per share.
The company attributed the plunge in the latest quarter to “lower commercial revenues” from the sales of its COVID-19 vaccine worldwide, which it said was largely driven by the “endemic-level demand” for the shot.
Also contributing to the biotech’s net loss was a more aggressive investment strategy in research and development. BioNTech pumped around $546 million into its R&D activities, up from nearly $360 million during the same period last year. The increase in spending was due to progressing clinical studies and a larger workforce, resulting in greater wage, benefits and social security expenses.
Despite a steep drop in its Q1 revenue, CEO Ugur Sahin struck a positive note in the company’s statement on Monday, focusing instead on BioNTech’s pipeline and upcoming milestones.
“In the past weeks, we have reported positive preliminary data for both our individualized and off-the-shelf mRNA-based candidates,” which further demonstrate the strong potential of the biotech’s core technologies, Sahin said. For 2024, BioNTech plans to develop a variant-adapted COVID-19 vaccine, as well as advance its cancer programs, paying particular focus on its bispecific antibody and antibody-drug conjugate (ADC) assets.
Seeking to establish its footing in a post-COVID-19 world, BioNTech has upped its investments in oncology as a way to diversify its business. In October 2023, the biotech inked a potential $1 billion deal with Suzhou-based biotech MediLink Therapeutics to develop next-generation ADCs targeting the HER3 protein.
BioNTech in February 2024 also entered into a $250 million licensing and manufacturing agreement with Autolus Therapeutics to advance investigational CAR-T therapies for solid tumors.
Looking ahead to the rest of the year, BioNTech forecasts total group revenue of $2.69 billion to $3.34 billion. The company on Monday said that nearly all its expected 2024 revenues would come in at the end of the year. As of March 31, 2024, BioNTech had almost $18.25 billion in cash, cash equivalents and security investments.
Tristan Manalac is an independent science writer based in Metro Manila, Philippines. Reach out to him on LinkedIn or email him at tristan@tristanmanalac.com or tristan.manalac@biospace.com.
wow, even at last years Q1 of 3.5 million and this stock at this price is more than a bargain. Could be the best deal now in the entire OTC.
"The strategy to turn to AI focus will be the key driving force for growth! We will build up the business in terms of revenue, profits, technology to get ourselves ready for up listing."
LOL, gold running premium to platinum by $400 an ounce. i'll take the gold to fill my bags.
You can have the aluminum. LMAO
I think so too. Just got that feeling.
Trying for those ones again. In the past every ticker that would not let go of ones meant it was going higher.
I may take some more twos too. We'll see. I don't think the price of gold or many commodities will be going down for awhile
plus we have the carbon greenies who love it that we have olivine in abundance. I don't care much for the greenies jibe but
hey, I'll take their dough and convert it to gold.
that would be one wild swing.
i doubt this goes to infinity. and i doubt we see zero.
even half way to heaven then back half way to hell.
it would be some nice movement for a change.
the macro trend is seeing the return of manufacturing to the usa.
china is imploding while many big usa companies are packing their china bags for home sweet home.
this is right up our alley. maybe this rising tide will lift our boat.
If I held those claims I would put up the dough myself. They are sitting on a highly mineralized piece of ground.
oh i get it, let's do the dance the two step.
Couldn't get my ones? Why not? Lots went for half way between one and two... but not retail.
MM's are loading for a client "insider"? and for themselves? Better take some twos.
Maybe we get a surprise early or middle of next week.
Looking forward to the soon developing business combinations. PR's will be coming soon I do believe.
Alan Chow (N Tjandra)
@TPSAsiaPacific
·
Apr 25, 2023
Will be taking an executive role in $icnm. Will connect Viagoo smart logistics platform to http://Vite.asia.
vite.asia
Digital Platform for eCommerce and Logistics
VITE is a digital platform that supports eCommerce businesses with various technology services e.g.
then why are you here? and what happens if no RS or if it comes after the pps is out of the trips where it will be welcomed if for the right reasons.
I may take them all with a little help from my friends. Going up.
Your shorty opinion does not jive with reality. Sorry sucker, I love these bags filled with gold.
Be aware and forewarned. The rush is coming. I will be back to rub it in.
Have a beautiful weekend.
$NBRI$ 2024
I've been around a long time and buying. I love it when shorties pile on and give some great bargains. A reminder, a gold rush is going on.
Be forewarned, the pps will surge as the new CEO develops the company. Loving it, thanks again for the cheap shares.
$NBRI$
exacto good post
So so so, the pigeons learned to lie by following their proud FDA/CDC who of course led the biggest lie in history of mankind.
Ready for that booster pigeons? Better join the leronlimab crew while their is still time to grab em cheap.
Will those patents expire soon, lmao. Misiu provided the answer direct from the company. What legal had to say shut the naysayers down. And he did not even mention the additional patents that will be filed on the newer long lasting version.
$$CYDY$$ 2024 year of the catalysts. Up we go. We got it, they want it, they will pay to have a nibble.
By Zachary Stieber
May 01, 2024
U.S. Centers for Disease Control and Prevention (CDC) officials found evidence that the Pfizer-BioNTech and Moderna COVID-19 vaccines caused multiple deaths before claiming that there was no evidence linking the vaccines to any deaths, The Epoch Times has learned.
Better go quick and check out Moderna profits way way down, unusual borrowing go on for Puffy Pfuzzy Pfizer. Guess I will go add to my shorts over at Pfizer. Hey fung dirt, how's those dividends holding up? LMAO.
What's the name of it? There is also a MacDonalds next to Burger King and KFC.
Oh I love polls. How many on Ihub are long on CYDY? How many short? Now what we need is a poll to find out how many members of Congress took the jab. What many many not know is that members of Congress did not have to follow any mandates. So did they line up like good lil pigeons. How many took the AstraZeneca jab or before that the J&J jab ... all with heaping praise from the FDA. So how many at the FDA got the jabs? I bet very few. Now, these major pharma players ... all on the big boards but of course previously at one time were mostly on the OTC until they got their amazing approvals from the soul bros at the FDA. Well now bully for the polls and the participants who took the plunge. I feel sorry for those who believed in the system and go duped. See what lack of real DD can do? This is why I trust in CytoDyn and leronlimab, Trust nobody but your own God given brain unless you love eating soylent green. Two thumbs up for Charlton Heston. So pigeons who know it all...belly on up for your next round of jab junk and keep trashing the highly likely miracle drug called leronlimab...the one with no secondary ailments hardly to speak of like maybe a headache or runny nose.
Stroke anyone? Altered menstrual cycle? Long Covid? Heart attacks? Cancer? Compromised immune system? Well, the secondary affects are not pretty for jab junkies where now the uptick of so many conditions especially cancers are skyrocketing since 2021 jabs began. Oh those nasty stats. Oh those nasty polls. Oh, here comes the stroke of FDA genius. https://www.theepochtimes.com/epochtv/vaccine-manufacturer-finally-admits-to-stroke-side-effect-facts-matter-5640630?src_src=enewsnoe&src_cmp=etv1-2024-05-01&est=AAAAAAAAAAAAAAAAdbAmeh0exsTo9bIGsWoXCLt3DMv%2BeZd%2FEugtIdyHPONOLA%3D%3D
Not to worry, in the UK and Canada the taxpayers foot the bill for the lawsuits!
$$CYDY$$ 2024 The year of the catalysts. We got it, they want it, they will pay to collaborate. oh yes, keep digging Sidley! So now, when will the studies and trials resume that the FDA so hastily assisted in protocol development ... as the deadly duo conspired to take the money and run. But who dangled this carrot? Truth will prevail and pigeons will be grounded. In the meantime, get back in line pigeons and bend over for the latest and greatest.
what's amazing is the speed the pigeons can fly when covering their shorts. we may get to see them lift off and haul ass for awhile this week like fung dirt last month.
trials and studies being formulated since holds were lifted. going to be so much fun when these are announced especially should there be some collaboration with another pharma.
$$CYDY$$ 2024
Good article but will it work on pigeons? If so, stock will fly the coop.
https://www.thisoldhouse.com/yards/22756894/best-chicken-coop
Seems they are getting to be the only ones who love the FDA and Pig Pharma
https://endpts.com/pharma-reputation-slips-among-patient-advocacy-groups-according-to-annual-survey/
$2024$ $$$CYDY$$$
P and D, scam, shorts, whatever. These often come out of the dark with lightening speed.
Just be ready should this happen again. It is high time and the hint was the CEO buying.
Let's see what happens.
You can tell the shorts as they come out of the wormwood whenever some strong bullish news begins to hit.
No Form 4's since 2014 someone posted. That is strong evidence things are getting ready to turn with the CEO
investing personal monies. Things are too long overdue for a turn around so expectations are high that the time is
ripe. We shall see.
The products can be made here I believe. "LAKE FOREST, Calif.--(BUSINESS WIRE)--Mar. 19, 2024-- Liquidmetal® Technologies, Inc. (OTCQB: LQMT), On March 15, 2024, Liquidmetal Technologies Inc. (the “Company”) entered into an Amended License Agreement to expand its existing agreement with Amorphology, Inc., a developer and producer of specialized BMG applications based in Pasadena, CA.
The Amended License Agreement grants Amorphology a non-exclusive royalty bearing license to utilize the Company’s technology to manufacture and sell amorphous metal parts and components.
“Amorphology looks forward to its enhanced and optimized partnership with Liquidmetal Technologies, bringing deep materials science and amorphous metals expertise, high precision manufacturing capabilities, and a domestic US production facility, to meet increased demand in the aerospace, defense, medical device, and robotics industries. This optimized partnership will enable both companies to gain greater market traction and allow for more widescale adoption of amorphous metal technology,” said Glenn Garrett, Amorphology CTO.
“We are extremely excited about having Amorphology as our global partner in advancing amorphous alloy technology. Not only will the Company be able to take advantage of a new revenue stream, but the partnership will allow us to have a local, US manufacturing source to pursue applications that would otherwise be prohibited due to customers requiring US manufacturing as well as legal and/or geo-political restrictions. This gets us one step closer to having our technology be adopted on a mass scale,” said Tony Chung, CEO for the Company.
Cowboy up. I like riding those bombs myself.
It could be a metaphor for riding the truth to the end...where ever that may be.
Where there is truth there is light. Some sunshine is reflecting off the liquid metal
a bit more. I see more than a few rays of hope because after all, this liquid metal
makes for better mouse traps.
"The Isolite 3 also incorporates Liquidmetal into the product design, making the device lighter, yet stronger than previous versions."
Fetterman is starting to improve a bit here lately which is surprising and delightful.
Now, the DEA drags their feet because they support the FDA that slows down everything
that would compete with Pig Pharma. So with time the chain is developing some weak links
and at some point it will break. When it does, the whole MJ arena will explode like a precision
air strike over Iran. In the meantime, this company and so many others are gearing up to be
ready in good shape when that day does occur.
It's all rosey from here on too. Let her rock!!
Thinking a good move might be to spin off the mill and declare a dividend to investors for the new entity.
Shorts would absolutely freak out.
https://www.investopedia.com/ask/answers/042215/if-investor-short-dividendpaying-stock-record-date-are-they-entitled-dividend.asp#:~:text=Key%20Takeaways,lender%20of%20the%20borrowed%20shares
Me too
and now up 77%. How that must hurt. Ouch!! Did FungSquirt get fungicided? LMAO
Maduro in talks with Rothchilds for help with 154 Billion debt. Maybe OCLN can shift over to Venezuela.
I think they do. Building basically a new company is not an overnight affair. So far so good although I am not a big fan of CCP,
I really like the old Chinese Culture which touches the deep soul in many around the world as seen through www.shenyun.org